Pancreatic Cancer Clinical Trials and Accrual in the United States

201387 citationsJournal Articlebronze Open Access

Authors

William Hoos · Pancreatic Cancer Action Network

Porsha M. James · Pancreatic Cancer Action Network

Lola Rahib · Pancreatic Cancer Action Network

Anitra W. Talley · Pancreatic Cancer Action Network

Julie Fleshman · Pancreatic Cancer Action Network

Lynn M. Matrisian · Pancreatic Cancer Action Network

Abstract

Overall trial enrollment indicates that pancreatic cancer trials open in 2011 would require 6.7 years on average to complete accrual. These results suggest that harmonizing patient supply and demand for clinical trials is required to accelerate progress toward improving survival in pancreatic cancer.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Ethics in Clinical Research Cancer Genomics and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 31, Issue 27, pp. 3432-3438

DOI: 10.1200/jco.2013.49.4823

Field-Weighted Citation Impact: 3.24